GUANINE NUCLEOTIDE BINDING PROTEIN BETA-GAMMA DIMERS--STRUCTURE AND FUNCTION

鸟嘌呤核苷酸结合蛋白 β-γ 二聚体——结构和功能

基本信息

项目摘要

The quanine-nucleotide binding regulatory proteins (G-proteins) are alpha1beta1gamma1 heterotrimers which function as transmembrane signal transducers by coupling receptors for extracellular stimuli to intracellular effectors (enzymes, ion channels). G-proteins constitute a diverse family distinguished by specific receptor and effector interactions which in turn are determined by the structure of the three constituent subunits. The alpha subunit binds quanine nucleotides and has a well established role in effector modulation. The beta and gamma subunits are tightly associated as a beta gamma complex, comprising a single functional entity which, like the alpha subunit, is absolutely required for G-protein interaction with receptor. An effector modulatory role for the beta gamma complex is becoming increasingly apparent in several systems. The present research emphasizes the role of the beta gamma complex in G-protein-mediated signal transduction. We have used subunit specific peptide antibodies to probe regions of the beta gamma complex important for functional interaction with the alpha subunit and to monitor expression of recombinant subunits. Site directed mutagenesis has been used to study the assembly, processing and effector function of the beta gamma complex in both transient and stable transfected cell systems. These studies may elucidate the contribution of the beta gamma subunit complex to the receptor and effector selectivity characteristic of G-proteins and to the adaptive responses pursuant to agonist stimulation. GRANTS=Z01DK59005 Nephrogenic diabetes insipidus (NDI) is an inherited X-lined disorder in which affected subjects are resistant ot the actions of vasopressin (AVP) on renal medullary cells responsible for water concentration. Clinical manifestations include severe polydipsia and polyuria, and resultant severe dehydration can lead to cerebral swelling and death. Treatment with a potent AVP analog (DDAVP, useful in other forms of DI, is in-effective in NDI because of end-organ resistance to tahe hormone. The renal actions of AVP are mediated through a V2 type receptor linked via the Gs protein to stimulation of the 2nd messenger CAMP. In theory, the inherited gene defect could be located anywhere along the signal transduction path, but indirect evidence suggested a likely receptor defect. The recent cloning of a human V2 receptor permitted chromosomal localization studies which showed that the receptor is localized to Xq28, the site of the gene defect as determined by family linkage studies. This strongly suggested but did not prove that a receptor gene mutation is the underlying defect in NDI. We have obtained genomic DNA samples on multiple families with NDI, and in three families thus far have identified mutations predicted to disrupt formation of a normal V2 receptor. These findings have important implications for our under- standing of the pathogenesis of NDI and of normal V2 receptor structure and function, for identification of affected subjects and carriers, and eventually for gene therapy of the disease.
奎宁-核苷酸结合调节蛋白(G-蛋白)是 作为跨膜信号的α1β1伽马1异三聚体 通过将细胞外刺激受体偶联到 细胞内效应物(酶、离子通道)。G蛋白构成 以特定受体和效应器区分的不同家族 相互作用又由三者的结构决定 组成亚单位。α亚基与奎宁核苷酸结合, 在效应器调节中起到了很好的作用。贝塔和伽马 亚基作为β-伽马复合体紧密相连,包括一个 单个功能实体,就像阿尔法亚单位一样,绝对是 G蛋白与受体相互作用所必需的。效应器 贝塔-伽马复合体的调节作用越来越大 在几个系统中都很明显。本研究强调了这一角色 G蛋白介导的信号转导中的β-伽马复合体。 我们已经使用亚单位特异性多肽抗体来探测 β-伽马复合体对与阿尔法的功能相互作用很重要 并监测重组亚基的表达。立地 定向诱变技术已被用于研究DNA的组装、加工和 瞬变和稳定状态下β-伽马复合体的效应函数 转基因细胞系统。这些研究可能会阐明这一贡献 受体和效应器的β-γ亚单位复合体 G蛋白的选择性特征及其对适应性反应的影响 根据激动剂刺激。 赠款=Z01DK59005 肾源性尿崩症(NDI)是一种遗传性X线疾病 受影响的对象对加压素的作用有抵抗力 (AVP)在肾髓质细胞上与水分浓度有关。 临床表现包括严重的多饮多尿,以及 由此产生的严重脱水会导致脑肿胀和死亡。 用有效的AVP类似物(DDAVP,在其他形式的DI中有用, 在NDI中无效,因为终末器官对塔赫激素耐药。 AVP的肾脏作用是通过与V2型受体相连的途径实现的 通过Gs蛋白刺激第二信使cAMP。从理论上讲, 遗传基因缺陷可能位于信号的任何位置 转导途径,但间接证据表明一个可能的受体 叛逃。人类V2受体允许染色体的最新克隆 定位研究表明受体定位于 Xq28,由家系连锁决定的基因缺陷位置 学习。这强烈地表明,但并不能证明受体基因 突变是NDI的潜在缺陷。我们已经获得了基因组DNA 多个患有NDI的家庭的样本,到目前为止有三个家庭 已经确定了预测会扰乱正常V2形成的突变 受体。这些发现对我们的儿童-- NDI发病机制及正常V2受体结构的认识 和功能,用于识别受影响的对象和携带者,以及 最终用于疾病的基因治疗。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

W SIMONDS其他文献

W SIMONDS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('W SIMONDS', 18)}}的其他基金

GUANINE NUCLEOTIDE BINDING PROTEIN BETA-GAMMA DIMERS--STRUCTURE AND FUNCTION
鸟嘌呤核苷酸结合蛋白 β-γ 二聚体——结构和功能
  • 批准号:
    3754551
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
GUANINE NUCLEOTIDE BINDING PROTEIN BETA-GAMMA DIMERS--STRUCTURE AND FUNCTION
鸟嘌呤核苷酸结合蛋白 β-γ 二聚体——结构和功能
  • 批准号:
    3840501
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
GUANINE NUCLEOTIDE BINDING PROTEIN BETA-GAMMA DIMERS--STRUCTURE AND FUNCTION
鸟嘌呤核苷酸结合蛋白 β-γ 二聚体——结构和功能
  • 批准号:
    5202013
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
GUANINE NUCLEOTIDE BINDING PROTEIN BETA-GAMMA DIMERS--STRUCTURE AND FUNCTION
鸟嘌呤核苷酸结合蛋白 β-γ 二聚体——结构和功能
  • 批准号:
    6161989
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Development of B cell functional studies on primary antibody deficiencies
一抗缺陷 B 细胞功能研究的进展
  • 批准号:
    502607
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
Antibody-Palladium Conjugates for Bioorthogonal Anti-Cancer Prodrug Activation
用于生物正交抗癌前药激活的抗体-钯缀合物
  • 批准号:
    EP/Y024540/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
ICF: AbVax Combination vaccination and broadly neutralising antibody therapy in HIV to induce a protective Tcell vaccinal effect, a mechanistic study
ICF:AbVax 联合疫苗接种和广泛中和 HIV 抗体疗法诱导保护性 T 细胞疫苗效应,一项机制研究
  • 批准号:
    MR/Y008847/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Enabling The Targeted Delivery Of DNA G-quadruplex Ligands using a Novel Antibody DAR-1 Platform
使用新型抗体 DAR-1 平台实现 DNA G 四链体配体的靶向递送
  • 批准号:
    BB/Y002180/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Thymus antibody-secreting cells: major players in autoimmunity.
胸腺抗体分泌细胞:自身免疫的主要参与者。
  • 批准号:
    502578
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
  • 批准号:
    24K19237
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
A Semi-Automated Antibody-Discovery Platform to Target Challenging Biomolecules
针对具有挑战性的生物分子的半自动化抗体发现平台
  • 批准号:
    MR/Y003616/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
Monitoring antibody protection against SARS-CoV-2 variants
监测抗体对 SARS-CoV-2 变体的保护作用
  • 批准号:
    MR/Y033698/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Pharmacokinetic analysis of antibody drug conjugate in tumor cells utilizing synchrotron soft X-ray imaging
利用同步加速器软 X 射线成像对肿瘤细胞中抗体药物偶联物进行药代动力学分析
  • 批准号:
    23H03716
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis research of anti-Sez6l2 antibody associated encephalopathy
抗Sez6l2抗体相关脑病的分析研究
  • 批准号:
    23K06940
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了